Trial Profile
A Phase I/IIa Study of CreaVax-HCC (Autologous Mature Dendritic Cells) to evaluate Safety and Efficacy in Patients with Hepatocellular carcinoma in TNM I to IIIC Stage after hepatic resection and/or other treatments (PEI, RFA, TACE)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Liver cancer vaccine (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2012 New trial record